Magellan Diagnostics, Inc. Expands Voluntary Recall of LeadCare® Test Kits

Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of diagnostic testing solutions and life science raw materials, today announced its wholly owned subsidiary, Magellan Diagnostics, Inc. (“Magellan”), expanded the Class I recall of its LeadCare® II Blood Lead Test Kits, LeadCare Plus® Blood Lead Test Kits, and LeadCare Ultra® Blood Lead Test Kits (the “LeadCare Test Kits”) for the detection of lead in whole blood.

LeadCare® Test KitsMeridian Bioscience, Inc.Medical Devices
Units Affected:    0
Recall Date:    Sep 1, 2021
Meridian Bioscience, Inc.
Last Published:    Sep 2, 2021
Official Site:    Link


Emert Number:    #-14797951217
Emert Status:    Notified